AUPP154298A0 - Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
- Google Patents
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP1542A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Le Couteur David George
Original Assignee
Le Couteur D G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Couteur D GfiledCriticalLe Couteur D G
Priority to AUPP1542ApriorityCriticalpatent/AUPP154298A0/en
Publication of AUPP154298A0publicationCriticalpatent/AUPP154298A0/en
Priority to AU22599/99Aprioritypatent/AU2259999A/en
Priority to PCT/AU1999/000065prioritypatent/WO1999038507A1/en
AUPP1542A1998-01-301998-01-30Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
AbandonedAUPP154298A0
(en)
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation
Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilators and other agents which increase hepatic oxygenation